Galderma Group N Cash Flow Reinvestment Rate
Galderma Group N cash flow reinvestment rate. Galderma Group N (GALD) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting CHF37.07 Million (capex CHF37.07 Million ) from operating cash flow of CHF475.06 Million. Explore Galderma Group N cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Galderma Group N (2021–2024)
Cash flow reinvestment rate of Galderma Group N from 2021 to 2024. Historical reinvestment intensity for Galderma Group N across 4 annual periods. Explore Galderma Group N capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Galderma Group N Cash Flow Reinvestment Rate by Year (2021–2024)
Galderma Group N cash flow reinvestment rate by year from 2021 to 2024. Year-by-year capital reinvestment analysis for Galderma Group N. For the full cash flow conversion analysis, see GALD cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.64x | CHF275.00 Million | CHF429.77 Million | CHF275.00 Million | ▼ -6.8% |
| 2023 | 0.69x | CHF102.02 Million | CHF148.64 Million | CHF102.02 Million | ▼ -52.1% |
| 2022 | 1.43x | CHF152.33 Million | CHF106.30 Million | CHF152.33 Million | ▲ +119.1% |
| 2021 | 0.65x | CHF117.03 Million | CHF178.92 Million | CHF117.03 Million | — |